Independent Research Analysts Give Draegerwerk AG & Co KGaA (ETR:DRW3) a €45.00 Price Target

Independent Research set a €45.00 ($52.33) target price on Draegerwerk AG & Co KGaA (ETR:DRW3) in a report released on Monday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Other equities analysts have also recently issued research reports about the stock. Hauck & Aufhaeuser set a €38.00 ($44.19) price objective on shares of Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research report on Wednesday, August 14th. Deutsche Bank set a €46.00 ($53.49) price objective on shares of Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research report on Wednesday, August 14th. Nord/LB set a €45.00 ($52.33) price objective on shares of Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research report on Friday, April 26th. Finally, Warburg Research set a €49.00 ($56.98) price objective on shares of Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating and six have given a hold rating to the stock. The company has a consensus rating of Hold and an average target price of €44.29 ($51.50).

ETR:DRW3 opened at €41.76 ($48.56) on Monday. The company has a debt-to-equity ratio of 33.52, a quick ratio of 1.19 and a current ratio of 2.00. The stock has a market capitalization of $317.38 million and a P/E ratio of 18.82. The company has a 50 day moving average price of €47.87 and a 200 day moving average price of €48.87. Draegerwerk AG & Co KGaA has a fifty-two week low of €38.32 ($44.56) and a fifty-two week high of €73.00 ($84.88).

About Draegerwerk AG & Co KGaA

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

See Also: What are the benefits of buying treasury bonds?

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.